ROBERT JOHN WHITE - 02 Aug 2021 Form 4 Insider Report for Medtronic plc (MDT)

Role: EVP & Pres. Medical Surgical
Signature: /s/ Thomas L. Osteraas, attorney-in-fact
Issuer symbol: MDT
Transactions as of: 02 Aug 2021
Net transactions value: -$643,025
Form type: 4
Filing time: 04 Aug 2021, 18:29:32 UTC
Next filing: 09 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MDT	Ordinary Shares	Tax liability	$643,025	-4,897	-11%	$131.31	40,674	02 Aug 2021	Direct	F1
transaction	MDT	Ordinary Shares	Award	$0	+6,095	+15%	$0.000000	46,769	02 Aug 2021	Direct	F2
holding	MDT	Ordinary Shares						1,500	02 Aug 2021	Family Trust	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MDT	Stock Option (Right to Buy)	Award	$0	+52,074		$0.000000	52,074	02 Aug 2021	Ordinary Shares	52,074	$131.26	Direct	F4
transaction	MDT	Stock Option (Right to Buy)	Award	$0	+1,085		$0.000000	1,085	02 Aug 2021	Ordinary Shares	1,085	$131.26	Direct	F4
transaction	MDT	Performance Share Units	Award	$0	+15,237		$0.000000	15,237	02 Aug 2021	Performance Share Units	15,237		Direct	F5, F6, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This balance increased by 649 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan.
F2	The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
F3	These securities are owned by the White Family Legacy Trust. The reporting person is the co-trustee. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
F4	These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
F5	Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F6	The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 15,237 shares will be issued. The actual number of shares to be issued could range from a low of 3,048 at minimum performance to a high of 30,474 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F7	Vests on August 2, 2024.